These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 13372956)

  • 1. The intracellular activation of pyrazinamide and nicotinamide.
    MACKANESS GB
    Am Rev Tuberc; 1956 Nov; 74(5):718-28. PubMed ID: 13372956
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of pyrazinamide and nicotinamide in acidic environments in vitro.
    McDERMOTT W; TOMPSETT R
    Am Rev Tuberc; 1954 Oct; 70(4):748-54. PubMed ID: 13197751
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vitro determination of the antimycobacteric activity of pyrazinamide].
    BASILICO F; BOSISIO E; GRASSI C
    G Ital Della Tuberc; 1956; 10(4):225-7. PubMed ID: 13366033
    [No Abstract]   [Full Text] [Related]  

  • 4. The antituberculous activity of pyrazinamide in vitro and in the guinea pig.
    STEENKEN W; WOLINSKY E
    Am Rev Tuberc; 1954 Aug; 70(2):367-9. PubMed ID: 13180876
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of significant in vitro sensitivity of Mycobacterium tuberculosis to pyrazinamide on three different solid media.
    TARSHIS MS; WEED WA
    Am Rev Tuberc; 1953 Mar; 67(3):391-5. PubMed ID: 13031058
    [No Abstract]   [Full Text] [Related]  

  • 6. A new method for the differentiation of human tubercle bacilli from other types of mycobacteria, using nicotinamide-containing medium (nicotinamide test). A preliminary report.
    TAN THIAM HOK
    Am Rev Respir Dis; 1962 Jul; 86():94. PubMed ID: 13919439
    [No Abstract]   [Full Text] [Related]  

  • 7. [Niacin test and nicotinamide test in isoniazid resistant strains of Mycobacterium tuberculosis].
    Hergt R; Ogbuoto G; Nimmich W
    Z Tuberk Erkr Thoraxorg; 1968 Dec; 129(5):329-34. PubMed ID: 4239321
    [No Abstract]   [Full Text] [Related]  

  • 8. Further observations of pyrazinamide alone and in combination with other drugs in experimental tuberculosis.
    STEENKEN W; WOLINSKY E; SMITH MM; MONTALBINE V
    Am Rev Tuberc; 1957 Oct; 76(4):643-59. PubMed ID: 13470312
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liver function and pyrazinamide therapy of pulmonary tuberculosis].
    SACCO F; ZUCCHETTI B; GUALA B; GUERRA P
    Gazz Med Ital; 1957 Jan; 116(1):22-5. PubMed ID: 13427967
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the tuberculostatic effect of pyrazinamide].
    SCHARL R
    Z Tuberk Erkr Thoraxorg; 1959; 112():306-9. PubMed ID: 14442461
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pyrazinamide (PZA) in the therapy of tuberculosis].
    SCHWEIGER O
    Tuberkulozis; 1957; 10(7-9):206-8. PubMed ID: 13530261
    [No Abstract]   [Full Text] [Related]  

  • 12. The anti-tuberculous activity of some derivatives of p-aminosalicylic acid, nicotinic acid, and isonicotinic acid.
    THAYER JD; SELIGMAN RB
    Antibiot Chemother (Northfield); 1955 Mar; 5(3):129-31. PubMed ID: 24543399
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical use of pyrazinamide; early therapeutic results].
    SERI I
    Tuberkulozis; 1957; 10(10-12):283-5. PubMed ID: 13557034
    [No Abstract]   [Full Text] [Related]  

  • 14. Ineffectiveness of nicotinamide and isoniazid in the treatment of pulmonary tuberculosis.
    JORDAHL C; DES PREZ R; DEUSCHLE K; MUSCHENHELM C; McDERMOTT W
    Am Rev Respir Dis; 1961 Jun; 83():899-900. PubMed ID: 13790670
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyrazinamide and viomycin in the surgical treatment of pulmonary tuberculosis.
    PECORA DV
    Am Rev Tuberc; 1958 Jan; 77(1):83-92. PubMed ID: 13498295
    [No Abstract]   [Full Text] [Related]  

  • 16. ISONIAZID trials.
    Lancet; 1952 Sep; 2(6732):471-2. PubMed ID: 14956048
    [No Abstract]   [Full Text] [Related]  

  • 17. Nitrate reductase assay for the rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.
    Martin A; Cubillos-Ruiz A; Von Groll A; Del Portillo P; Portaels F; Palomino JC
    J Antimicrob Chemother; 2008 Jan; 61(1):123-7. PubMed ID: 17981833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reflections and research on the antitubercular activity of pyrazinamide].
    BASILICO F; BOSISIO E; GRASSI C
    G Ital Della Tuberc; 1956; 10(4):218-20. PubMed ID: 13366031
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and biological investigations on the new antituberculosis drugs (pyrazinamide and cycloserine).
    ZORINI AO; SPINA G; DE SIMONI GE
    Dis Chest; 1958 Jul; 34(1):27-46. PubMed ID: 13561872
    [No Abstract]   [Full Text] [Related]  

  • 20. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug.
    MCCUNE RM; MCDERMOTT W; TOMPSETT R
    J Exp Med; 1956 Nov; 104(5):763-802. PubMed ID: 13367342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.